<DOC>
	<DOCNO>NCT00807989</DOCNO>
	<brief_summary>To evaluate efficacy usual monotherapy low dose combination Lamotrigine Valproate . Low dose combination may effective tolerable low dose VPA reduce Lamotrigine metabolism .</brief_summary>
	<brief_title>The Efficacy Safety Low Dose Combination LTG VPA Compared CBZ Monotherapy</brief_title>
	<detailed_description>An Open label , Randomized , Multicenter Clinical Trial Compare Efficacy Safety Lamotrigine / Valproate Coadministration Carbamazepine Initial Pharmacotherapy Epilepsies</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Age â‰¥16yr old Who diagnose epilepsy definitely Who minimum 2 unprovoked seizure minimum 1 seizure previous 3 month Who need AED therapy AED medication previous 1 year ( exclude emergency medication le 2weeks ) Who pregnant Who report seizure diary him/herself caregiver Who agree trial provide inform consent . Type seizure : generalize tonicclonic , complex partial , and/or simple partial motor seizure ; Who progressive CNS disease . Has serious systemic psychiatric disease Who suitable investigator ( uncooperative ) Who fill diary check card Is pregnant , breastfeeding , plan become pregnant Exclusion absence s. juvenile myoclonic epilepsy , atonic seizure , alcohol substance abuser , mental retardation etc . Who cancel agree trial provide inform consent . ALT , AST , bilirubin BUN/Cr level twice normal range WBC value 2000 less , Hb value 9.0 less , platelet count 100,000 less CBC Who take investigation product participate study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>